Charles Thomas Reilly - Chief Financial Officer, Cara Therapeutics, Inc

As of March 4, 2022


What is Charles Thomas Reilly's Net Worth?

The current estimated net worth of Cara Therapeutics, Inc's Chief Financial Officer, Charles Thomas Reilly, is estimated to be about $97.06K . Charles Thomas Reilly owns about 37,811 units of Cara Therapeutics, Inc common stock. In the last 2 years at Cara Therapeutics, Inc, Charles Thomas Reilly has sold an estimated value of $51.41K worth.

What is Charles Thomas Reilly's Past Insider Trading?

Charles Thomas Reilly's largest sale order was 1,982 units , worth over $28.14K on September 1, 2021. In total, Charles Thomas Reilly has made about 6 transactions over 2 years of their time at Cara Therapeutics, Inc. Charles Thomas Reilly usually trades in March, with the busiest year in 2021. The most recent transaction was a sale order of 2,044 units , worth over $23.26K on March 4, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Charles Thomas Reilly's' Mailing Address?

  • Mailing address is C/o Cara Therapeutics, Inc. 4 Stamford Plaza, 107 Elm Street Stamford CT 06902 CT

What are Cara Therapeutics, Inc's Past Insider Trades?

Cara Therapeutics, Inc's most recent insider trade came on April 5, 2022 by Scott Terrillion who sold 1,642 units worth $19.56K . In the last 8 years, insiders at Cara Therapeutics, Inc have sold an estimated value of $26.43M and bought an estimated value of $21.23M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Phd Frederique Menzaghi, Chief Scientific OffSVP-R&D,  Derek Chalmers, President & CEO,  and Jeffrey Ives, Director .

Cara Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1